Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have signed a written consent form agreeing to take part and to the use of their personal data
- People who are male and over 40 years of age
- People who have had an MRI scan of the prostate done following specific guidelines, with results reported using a standard scoring system called PI-RADS version 2
- People whose MRI scan shows signs that the cancer has started to push against or beyond the outer edge of the prostate
- People whose prostate cancer has been confirmed by a tissue sample (biopsy) to be a specific common type called acinar prostate cancer, found in the area identified on the MRI
- People who do not have large (greater than 3 cm), bone, or organ-based cancer spread in the pelvis or abdomen
- People whose doctors have determined are suitable for surgery to remove the prostate and nearby lymph nodes
- People who are in good general health and able to carry out daily activities with little to no limitation (confirm with trial site)
- People with a life expectancy of at least 5 years
- People who wish to preserve sexual function and who are currently sexually active, with a score above 17 on a standard questionnaire measuring erectile function
- People whose medical records from before the study are available
- People who are able to attend all required follow-up appointments and agree to have their data collected
Who may not be able to join:
- People whose prostate cancer is of a less common or unusual tissue type
- People whose PSA level was above 100 ng/ml when they were first diagnosed
- People who are unable to have an MRI scan (for example, due to having a pacemaker or severe claustrophobia), or whose MRI scan is not of good enough quality to create the required 3D images used in this study
- People who are currently receiving other cancer treatments, including experimental hormone therapies
- People who have serious or uncontrolled health conditions, including active uncontrolled infections
- People who have dementia or a psychiatric condition that could make it difficult to follow the study requirements or to understand and sign the consent form
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Enrico Checcucci, MD, Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo
Phone: +390119933632
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Perioperative surgical oncological outcomes
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.